Mytrex Health Technologies, Inc. (TPEX:4431)
Taiwan
· Delayed Price · Currency is TWD 17.20
-0.10 (-0.58%)
Apr 29, 2026, 1:21 PM CST
TPEX:4431 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,945 | 1,759 | 1,293 | 1,472 | 291.62 | Upgrade
|
| Revenue Growth (YoY) | 10.59% | 36.02% | -12.14% | 404.61% | -71.51% | Upgrade
|
| Cost of Revenue | 1,702 | 1,537 | 1,101 | 1,232 | 251.48 | Upgrade
|
| Gross Profit | 242.58 | 221.55 | 192.35 | 239.4 | 40.14 | Upgrade
|
| Selling, General & Admin | 305.43 | 337.77 | 294.25 | 310.74 | 53.65 | Upgrade
|
| Research & Development | 3.57 | 2.86 | 12.3 | 16.4 | 1.98 | Upgrade
|
| Other Operating Expenses | -41.29 | -42.12 | -43.65 | -40.87 | -0.01 | Upgrade
|
| Operating Expenses | 267.85 | 299.18 | 264.17 | 286.15 | 55.6 | Upgrade
|
| Operating Income | -25.27 | -77.63 | -71.83 | -46.74 | -15.46 | Upgrade
|
| Interest Expense | -5.07 | -6.13 | -6.22 | -5.21 | -1.58 | Upgrade
|
| Interest & Investment Income | 3.97 | 2.89 | 2.3 | 1.15 | 0.67 | Upgrade
|
| Earnings From Equity Investments | 1.08 | -0.26 | 0.94 | 1.66 | -0.86 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.3 | 2.6 | 0.76 | 10.24 | -4.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.32 | 18.26 | 20.05 | 20.9 | 0.15 | Upgrade
|
| EBT Excluding Unusual Items | -25.9 | -60.27 | -54 | -18.01 | -21.13 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -1.06 | 33.34 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.77 | 17.51 | -4.1 | 8.68 | -0.16 | Upgrade
|
| Asset Writedown | -1.26 | -41.65 | 0.92 | -51.47 | -25.65 | Upgrade
|
| Other Unusual Items | 8.43 | 0.09 | - | - | - | Upgrade
|
| Pretax Income | -21.5 | -84.32 | -57.18 | -61.86 | -13.6 | Upgrade
|
| Income Tax Expense | 4.35 | 0.51 | 1.11 | 7.1 | 0.45 | Upgrade
|
| Earnings From Continuing Operations | -25.85 | -84.83 | -58.29 | -68.96 | -14.05 | Upgrade
|
| Minority Interest in Earnings | 9.25 | 2.46 | 2.07 | -22.94 | 0.04 | Upgrade
|
| Net Income | -16.6 | -82.38 | -56.22 | -91.9 | -14.01 | Upgrade
|
| Net Income to Common | -16.6 | -82.38 | -56.22 | -91.9 | -14.01 | Upgrade
|
| Shares Outstanding (Basic) | 37 | 37 | 37 | 37 | 37 | Upgrade
|
| Shares Outstanding (Diluted) | 37 | 37 | 37 | 37 | 37 | Upgrade
|
| Shares Change (YoY) | - | - | - | 0.00% | 11.05% | Upgrade
|
| EPS (Basic) | -0.45 | -2.25 | -1.54 | -2.52 | -0.38 | Upgrade
|
| EPS (Diluted) | -0.45 | -2.25 | -1.54 | -2.52 | -0.38 | Upgrade
|
| Free Cash Flow | 196.17 | 22.75 | -26.03 | 36.98 | -16.46 | Upgrade
|
| Free Cash Flow Per Share | 5.37 | 0.62 | -0.71 | 1.01 | -0.45 | Upgrade
|
| Gross Margin | 12.47% | 12.60% | 14.88% | 16.27% | 13.76% | Upgrade
|
| Operating Margin | -1.30% | -4.41% | -5.56% | -3.18% | -5.30% | Upgrade
|
| Profit Margin | -0.85% | -4.68% | -4.35% | -6.25% | -4.80% | Upgrade
|
| Free Cash Flow Margin | 10.09% | 1.29% | -2.01% | 2.51% | -5.64% | Upgrade
|
| EBITDA | 32.31 | -2.56 | 4.65 | 36.75 | 23.65 | Upgrade
|
| EBITDA Margin | 1.66% | -0.15% | 0.36% | 2.50% | 8.11% | Upgrade
|
| D&A For EBITDA | 57.57 | 75.07 | 76.48 | 83.49 | 39.11 | Upgrade
|
| EBIT | -25.27 | -77.63 | -71.83 | -46.74 | -15.46 | Upgrade
|
| EBIT Margin | -1.30% | -4.41% | -5.56% | -3.18% | -5.30% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.